3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow rolapitant: new trials by email Literature Review of rolapitant trials Research Report on rolapitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide Rolapitant, Ondansetron - Chemo-radiation Induced Nausea and Vomiting | Phase 2 | Completed | Duke University | 48 | 2017-10-09 | 2023-07-11 |
| Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888) SCH 619734, Placebo Dose 1 - Cough | Phase 2 | Completed | Merck Sharp & Dohme LLC | 35 | 2007-01-01 | 2013-11-27 |
| A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED) SCH 619734 Dose 1, SCH 619734 Dose 2, SCH 619734 Dose 3 - Nausea, Vomiting | Phase 2 | Completed | Schering-Plough | 450 | 2006-09-01 | 2009-10-23 |
Nausea (2) · Vomiting (2) · Cough (1) · Glioma (1)
Duke University (1) · Merck Sharp & Dohme LLC (1) · Schering-Plough (1)
United States (1)